IRVINE, Calif., June 15 /PRNewswire-FirstCall/ -- Dermisonics, Inc. (OTC Bulletin Board: DMSI.OB - News), a medical device company focused upon the development of a painless, needle-free drug-delivery technology, announces that it has received a Notice of Allowance from the United States Patent & Trademark Office on its second U-Strip(TM) patent application, concerning an ultrasonic drug delivery system.
